GHK-Cu copper peptide complex chemistry

Why GHK-Cu is a coordination-standard problem

GHK-Cu looks simple on a catalog line: a Gly-His-Lys tripeptide coordinated to copper(II). For in-vitro research, the hard part is not naming the residues. The hard part is proving that the released lot represents the intended copper-peptide complex rather than a mixture of free peptide, copper salt, hydrated species, and counter-ion forms. <a href="/product/cp-035">CP-035 GHK-Cu</a> should therefore be read as a coordination chemistry reference standard, not as a generic cosmetic peptide. Canada Peptides can link it beside <a href="/product/cp-060">CP-060 Argireline</a>, <a href="/product/cp-061">CP-061 Matrixyl</a>, and <a href="/product/cp-062">CP-062 SNAP-8</a>, but the COA questions are different.

The residue-level backbone gives three coordination handles: the N-terminal amine, the peptide amide nitrogen after deprotonation under suitable pH, and the histidine imidazole. The lysine side chain mainly changes solubility and charge state rather than acting as the primary copper-binding site. That division matters because HPLC-MS verified peptide identity alone can confirm the Gly-His-Lys backbone while still leaving stoichiometry and copper occupancy to be checked by orthogonal evidence. A release dossier should therefore pair mass confirmation with copper content, chromatographic purity, and a counter-ion note.

Stoichiometry: one peptide, one copper, and the hydration question

The catalog molecular weight for CP-035 is 402.9 Da. That number is useful as a receiving check, but it should not be treated as the only structural proof. Copper complexes often travel through analytical workflows with different apparent masses depending on protonation, adduct formation, counter-ion exchange, and hydration. A clean COA should state whether the reported molecular weight is the free complex, a salt-adjusted value, or the lot-specific value calculated from the assigned counter-ion. For procurement teams, the practical question is simple: can the COA reconcile the label mass with the mass spectrum and the stated copper assay?

Stoichiometry also affects how the material should be compared across suppliers. A nominal GHK-Cu product can vary if one supplier reports free peptide equivalent and another reports copper complex equivalent. That difference changes the apparent amount of peptide in a vial without changing the sequence. A reference standard file should therefore show the peptide identity line, the metal coordination line, and the salt or hydration line separately. When those lines are collapsed into one number, the reviewer loses the ability to compare like with like.

How HPLC-MS fits into a copper complex release file

HPLC-MS is still the central identity method, but it answers a narrower question than many buyers assume. It confirms that the Gly-His-Lys-derived species appears at the expected mass window and that the chromatographic main peak dominates the UV-absorbing material. It does not, by itself, quantify all inorganic copper, all water, or all non-UV-absorbing residue. That is why the same release file should include reversed-phase HPLC, copper-sensitive identity or assay evidence, Karl Fischer water content, and residual-solvent screening.

A useful chromatogram for GHK-Cu should resolve free GHK from the copper complex and from common synthesis-related impurities. Free GHK is more polar and normally shifts earlier than a coordinated complex under a C18 gradient. Copper coordination can also change peak shape because the complex has different charge distribution and metal-centred interactions. The reviewer should ask whether the integration method treats shoulder peaks consistently and whether the MS trace confirms the main peak rather than a nearby adduct. The companion article on <a href="/research-guide/reading-a-coa">reading a COA</a> gives the general release-record frame.

Coordination state, pH, and formulation matrices

Copper-peptide coordination is pH-sensitive. At lower pH, protonated amide and imidazole sites compete with metal binding. At higher pH, deprotonated amide coordination becomes more favourable, but side reactions and precipitation risks may increase depending on buffer and ionic strength. A cosmetic raw material formulation team therefore needs more than a product name. It needs the lot pH window, the matrix used for compatibility testing, and a statement that the analytical method measured the species relevant to that matrix.

That is why a GHK-Cu article should link naturally to cosmetic peptide COA content without implying identical methods. <a href="/research-guide/cosmetic-peptide-coa-characterisation">Cosmetic peptide COA characterisation</a> covers acetylation, palmitoylation, and formulation-buffer compatibility. GHK-Cu adds copper stoichiometry and coordination-state verification to the same quality frame. The article on <a href="/research-guide/palmitoylated-pentapeptide-lipidation">palmitoylated pentapeptide lipidation chemistry</a> is another useful comparator because it shows how a small modification can dominate chromatographic behaviour.

Impurity paths specific to copper tripeptides

The first impurity class is free tripeptide. It may arise from incomplete coordination, ligand exchange, or sample preparation that shifts the equilibrium away from the copper complex. The second class is metal-related material: free copper salt, alternate copper-ligand species, or matrix-bound copper that does not appear as the main peptide complex. The third class is peptide-derived: oxidation at histidine-adjacent positions, hydrolysis products, or deletion sequences from synthesis. These categories require different methods, so a single purity number should never stand alone.

For Canada Peptides, the procurement-friendly presentation is a small number of clear lines: HPLC-MS verified identity, main-peak purity, copper stoichiometry or copper content, water content, residual solvents, lot number, and storage condition. Those lines tell a Toronto research buyer whether the vial is suitable as a research reference standard for in-vitro analytical work. They do not make a finished-product claim and they should stay framed as for in-vitro research use only and not for human or veterinary use.

How to cross-link the GHK-Cu article

The primary PDP link is CP-035, but a strong internal-linking pattern should also point readers to the broader cosmetic chemistry set. Argireline, Matrixyl, and SNAP-8 are not copper complexes, yet they share the same buyer workflow: confirm the modification state, read the COA, compare HPLC-MS identity, and check formulation-buffer relevance. Linking those PDPs helps a formulator move from one molecule to the adjacent quality questions without changing the page into a shopping list.

The glossary should support the same route. Terms such as <a href="/glossary/hplc-ms">HPLC-MS</a>, <a href="/glossary/counter-ion">counter-ion</a>, <a href="/glossary/lyophilizate">lyophilizate</a>, and <a href="/glossary/certificate-of-analysis">Certificate of Analysis</a> are the natural internal anchors. The result is a structural article that closes the orphaned-PDP gap for GHK-Cu while also strengthening the research-guide spine around analytical chemistry and cosmetic raw material formulation.

Summary

GHK-Cu is best handled as a copper coordination reference standard. The Gly-His-Lys peptide backbone, the copper occupancy, the counter-ion or hydration state, and the chromatographic main peak all need separate review. CP-035 should link to the cosmetic peptide family, but its release file needs a coordination-specific read rather than the acetylation or palmitoylation checks used for CP-060, CP-061, and CP-062.

The practical quality bar is straightforward: match the SKU to the verified catalog, confirm HPLC-MS identity, check copper stoichiometry, verify water and solvent lines, and keep the article framed for in-vitro research and cosmetic raw material formulation only.

Release-file review checklist

For release-file review, keep the chemistry anchored to the verified SKU list: CP-035, CP-060, CP-061, CP-062. Confirm sequence or scaffold, molecular weight, HPLC-MS verified identity, counter-ion or modification state, water content, and residual-solvent method before copying the article into a production CMS. Canada Peptides should keep each inline product reference tied to the lower-case PDP route and should keep the article language limited to research reference standard selection, analytical characterisation, and procurement traceability. If a future catalog update changes a molecular weight, adds a salt form, or introduces a new related product, revise the cross-links and the patch file before publication rather than editing the claim in isolation.

For GHK-Cu, human review should focus on the lot-specific copper-content method and on whether the catalog molecular weight is reported as free complex, salt form, or hydrated material. Do not infer the counter-ion from the article copy if the COA does not state it.

Procurement traceability notes

A procurement reader should be able to move from this article to a PDP, from the PDP to a lot COA, and from the COA to a reproducible method record without guessing. That means names, SKU codes, molecular weights, and analytical terms must stay consistent across the article body, glossary, and reverse-index patch. The article should therefore be handled as a controlled content asset: update the reviewed date, check the DOI links, rerun the banned-phrase scan, and confirm the article still links to at least three product pages and two research-guide resources before publication.

Publication integration notes

A production editor should keep this article connected to three content surfaces: the CP-035 PDP, the cosmetic chemistry cluster, and the glossary. The CP-035 PDP should stay the commercial anchor, while the article carries the deeper explanation of stoichiometry and metal coordination. Inline links to CP-060, CP-061, and CP-062 are there to help readers compare cosmetic reference standards, not to imply that acetylated, palmitoylated, and copper-coordinated materials share one release method. That difference is the whole point of the page.

The highest-risk copy error is over-defining the copper species beyond what the lot file proves. If a future COA states a counter-ion, hydration state, or copper assay method, the article can be tightened around that evidence. Until then, it should use careful language such as copper occupancy, coordination-state review, and lot-specific stoichiometry. This preserves scientific authority while staying procurement-friendly. It also keeps the page useful for long-tail searches around GHK-Cu, copper tripeptide complex, and HPLC-MS identity without fabricating a release detail.

References

1. Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+. FEBS Letters, 238(2), 343–346. DOI: 10.1016/0014-5793(88)80509-x80509-x) 2. Freedman, J. H., Pickart, L., Weinstein, B., Mims, W. B., & Peisach, J. (1982). Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry, 21(19), 4540–4544. DOI: 10.1021/bi00262a004 3. Sigel, H., & Martin, R. B. (1982). Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands. Chemical Reviews, 82(4), 385–426. DOI: 10.1021/cr00050a003 4. Wegrowski, Y., Maquart, F. X., & Borel, J. P. (1992). Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex Glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences, 51(13), 1049–1056. DOI: 10.1016/0024-3205(92)90504-i90504-i) 5. Siméon, A., Emonard, H., Hornebeck, W., & Maquart, F.-X. (2000). The tripeptide-copper complex glycyl-L-histidyl-L- lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 67(18), 2257–2265. DOI: 10.1016/s0024-3205(00)00803-100803-1)

Frequently asked questions

References

1. Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+. FEBS Letters, 238(2), 343–346. · link
2. Freedman, J. H., Pickart, L., Weinstein, B., Mims, W. B., & Peisach, J. (1982). Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry, 21(19), 4540–4544. · link
3. Sigel, H., & Martin, R. B. (1982). Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands. Chemical Reviews, 82(4), 385–426. · link
4. Wegrowski, Y., Maquart, F. X., & Borel, J. P. (1992). Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex Glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences, 51(13), 1049–1056. · link
5. Siméon, A., Emonard, H., Hornebeck, W., & Maquart, F.-X. (2000). The tripeptide-copper complex glycyl-L-histidyl-L- lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 67(18), 2257–2265. · link

References

1. Unknown author (2017). X-RAY STUDY OF Cu(II)GHK COPPER-CONTAINING PEPTIDE COMPLEXES. Журнал структурной химии. · DOI
2. Alshammari N., Platts J. (2020). Theoretical study of copper binding to GHK peptide. Computational Biology and Chemistry. · DOI
3. Choi H., Kang Y., Ryoo S. et al. (2012). Stem cell recovering effect of copper‐free GHK in skin. Journal of Peptide Science. · DOI
4. Katayama K., Armendariz-Borunda J., Raghow R. et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry. · DOI
5. Aguilar M. (n.d.). HPLC of Peptides and Proteins: Basic Theory and Methodology. HPLC of Peptides and Proteins. · DOI
6. Whitelegge J. (n.d.). HPLC and Mass Spectrometry of Intrinsic Membrane Proteins. HPLC of Peptides and Proteins. · DOI
7. Rauh M. (2012). LC–MS/MS for protein and peptide quantification in clinical chemistry. Journal of Chromatography B. · DOI
8. Merrifield R. (1963). Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. · DOI